Presentations Outline Strategies for Improving Personalized Cancer Care and Evaluating Timing for Radiotherapy Planning and Delivery
NEW YORK (September 11, 2014) – Members of the Department of Radiation Oncology at Montefiore Einstein Center for Cancer Care (MECCC) and Albert Einstein College of Medicine of Yeshiva University’s NCI–designated Albert Einstein Cancer Center will present new study findings at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO) revealing the impact socioeconomic status has on radiation treatment compliance, predictive indicators for clinical outcomes and on radiation therapy duration and dosing recommendations. ASTRO is being held September 14 – September 17 in San Francisco.
“Our team’s abstracts focus on how to enhance radiation planning for locally-advanced cancers, particularly in the liver and lung, which represent approximately 250,000 new cancer diagnoses each year,” said Shalom Kalnicki, M.D., professor and chair, Department of Radiation Oncology, MECCC and Einstein. “We will show the effect a patient’s socioeconomic status has on radiotherapy compliance, a significant problem for many people across the country. These studies represent our commitment to overcoming treatment barriers and providing new hope to people impacted by cancer in all its forms.”
This year’s conference will feature oral abstracts and poster presentations made by nationally and internationally renowned radiation oncologists and physicists. Findings will focus on prognostic markers for clinical outcomes and refining personalized therapies for liver tumors, non-small cell lung cancer, head and neck cancers and cervical cancer.
Following is a sample of Montefiore-Einstein studies to be presented at the meeting, which are embargoed until the time of presentation. Investigators are available for interviews specific to the data or to comment on topics of interest coming out of ASTRO 2014.